Persistent vancomycin and high-level gentamicin-resistant Enterococcus faecium bacteremia and intra-aortic thrombus in an extremely low birth-weight infant

被引:4
作者
Hapnes, N. [1 ]
Twomey, A. [1 ]
Knowles, S. [2 ]
机构
[1] Natl Matern Hosp, Dept Neonatol, Dublin 2, Ireland
[2] Natl Matern Hosp, Dept Microbiol, Dublin 2, Ireland
关键词
LINEZOLID TREATMENT;
D O I
10.1038/jp.2008.137
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Vancomycin-resistant Enterococcus (VRE) sepsis is emerging as a significant problem in the intensive care setting. The treatment at any age is challenging, but there is a dearth of information on this infection and its treatment in the very premature infant. We describe successful treatment of persistent bacteremia caused by Enterococcus faecium with vancomycin and high-level gentamicin resistance in a 10-day-old former 23-week premature male infant.
引用
收藏
页码:66 / 68
页数:3
相关论文
共 10 条
[1]   Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid [J].
Ang, JY ;
Lua, JL ;
Turner, DR ;
Asmar, BI .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (12) :1101-1103
[2]  
[Anonymous], European Antimicrobial Resistant Surveillance System (EARSS)
[3]   Linezolid versus vancomycin in the treatment of known or suspected resistant Gram-positive infections in neonates [J].
Deville, JG ;
Adler, S ;
Azimi, PH ;
Jantausch, BA ;
Morfin, MR ;
Beltran, S ;
Edge-Padbury, B ;
Naberhuis-Stehouwer, S ;
Bruss, JB .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (09) :S158-S163
[4]   Antibiotics and antifungals in neonatal intensive care units: A review [J].
Fanos, V. ;
Cuzzolin, L. ;
Atzei, A. ;
Testa, M. .
JOURNAL OF CHEMOTHERAPY, 2007, 19 (01) :5-20
[5]   Linezolid treatment of vancomycin-resistant Enterococcus faecium ventriculitis [J].
Graham, PL ;
Ampofo, K ;
Saiman, L .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (08) :798-800
[6]   Linezolid treatment of glycopeptide-resistant Enterococcus faecium in very low birth weight premature neonates [J].
Hoehn, R ;
Groll, AH ;
Schaefer, V ;
Bauer, K ;
Schloesser, RL .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 27 (03) :256-258
[7]   Impact of ontogeny on linezolid disposition in neonates and infants [J].
Kearns, GL ;
Jungbluth, GL ;
Abdel-Rahman, SM ;
Hopkins, NK ;
Welshman, IR ;
Grzebyk, RP ;
Bruss, JB ;
van den Anker, JN .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (05) :413-422
[8]   Linezolid in two premature babies with necrotizing enterocolitis and infection with vancomycin-resistant enterococcus [J].
Klingkowski, U ;
Huth, RG ;
Habermehl, P ;
Knuf, M .
KLINISCHE PADIATRIE, 2004, 216 (01) :21-23
[9]  
METHA DK, 2007, BRIT NATL FORMULARY, V55, P104
[10]   Safety and tolerability of linezolid in children [J].
Saiman, L ;
Goldfarb, J ;
Kaplan, SA ;
Wible, K ;
Edge-Padbury, B ;
Naberhuis-Stehouwer, S ;
Bruss, JB .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (09) :S193-S200